Sumitomo Chemical India Ltd

Sumitomo Chemical India Ltd

₹ 494 -3.72%
03 Jul - close price
About

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Key Points

Products
The company operates in various product segments, including insecticides, weedicides, fungicides, fumigants, rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. It markets proprietary products from its Japanese parent, Sumitomo Chemical Co., in agrochemicals, animal nutrition, and environmental health.[1]

The products comprise conventional chemistry sourced from SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC. [2]

  • Market Cap 24,643 Cr.
  • Current Price 494
  • High / Low 518 / 336
  • Stock P/E 70.0
  • Book Value 48.9
  • Dividend Yield 0.24 %
  • ROCE 19.8 %
  • ROE 14.6 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 34.5%

Cons

  • Stock is trading at 10.1 times its book value
  • The company has delivered a poor sales growth of 5.00% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
534 782 910 707 665 986 1,121 753 652 724 903 542 674
463 632 696 581 556 798 843 633 571 644 716 476 534
Operating Profit 71 150 215 127 109 188 278 120 81 81 188 66 140
OPM % 13% 19% 24% 18% 16% 19% 25% 16% 12% 11% 21% 12% 21%
5 5 8 6 7 5 11 13 16 18 25 27 27
Interest 1 2 2 2 1 1 1 1 1 1 1 1 1
Depreciation 13 11 11 11 11 11 15 11 14 14 16 16 17
Profit before tax 61 142 210 120 104 180 272 121 82 83 196 75 149
Tax % 12% 26% 26% 26% 28% 23% 26% 25% 12% 26% 27% 27% 26%
54 106 154 89 75 138 201 90 72 62 143 55 110
EPS in Rs 1.08 2.12 3.09 1.78 1.50 2.77 4.04 1.81 1.45 1.24 2.87 1.10 2.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,913 2,228 2,425 2,645 3,061 3,511 2,844
1,693 1,938 2,090 2,157 2,459 2,844 2,369
Operating Profit 220 291 335 488 602 667 475
OPM % 11% 13% 14% 18% 20% 19% 17%
30 1 -20 19 27 45 96
Interest 5 4 7 7 8 6 6
Depreciation 24 28 41 47 45 52 62
Profit before tax 221 260 267 453 576 654 503
Tax % 34% 36% 23% 24% 26% 23% 26%
145 166 205 345 424 502 370
EPS in Rs 4.10 6.92 8.49 10.06 7.40
Dividend Payout % 0% 38% 18% 12% 12% 12% 80%
Compounded Sales Growth
10 Years: %
5 Years: 5%
3 Years: 2%
TTM: -19%
Compounded Profit Growth
10 Years: %
5 Years: 16%
3 Years: 1%
TTM: -27%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 9%
1 Year: 11%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 20%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 275 275 499 499 499 499 499
Reserves 679 774 723 1,042 1,428 1,883 1,942
10 20 36 33 38 34 30
694 792 849 1,098 1,045 953 841
Total Liabilities 1,658 1,860 2,106 2,672 3,010 3,369 3,313
267 279 319 309 390 430 563
CWIP 9 8 10 14 35 71 23
Investments 0 0 86 290 356 239 346
1,383 1,572 1,690 2,058 2,228 2,629 2,381
Total Assets 1,658 1,860 2,106 2,672 3,010 3,369 3,313

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
47 78 221 425 222 389 757
-40 -35 -118 -283 -290 -327 -420
7 -65 -61 -47 -63 -73 -337
Net Cash Flow 15 -23 42 96 -131 -10 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 105 110 128 117 101 98 92
Inventory Days 203 193 146 185 198 157 136
Days Payable 176 136 122 145 109 86 96
Cash Conversion Cycle 133 166 152 157 189 169 132
Working Capital Days 116 119 112 98 129 138 174
ROCE % 27% 26% 32% 33% 29% 20%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
1.22% 1.32% 1.36% 1.69% 1.90% 2.05% 2.44% 2.40% 2.51% 2.58% 2.61% 2.74%
6.57% 6.13% 6.17% 6.36% 6.70% 6.39% 5.52% 5.50% 5.50% 6.06% 6.02% 6.63%
17.21% 17.55% 17.47% 16.95% 16.40% 16.54% 17.02% 17.09% 16.96% 16.33% 16.35% 15.61%
No. of Shareholders 78,6511,19,5611,50,5891,39,6011,33,6581,46,0631,44,0181,42,5961,56,1361,47,9071,45,0831,48,764

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls